VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies' Creditors Arrangement Act (Canada) (the "CCAA") and its ...
Dealmakers at BeiGene, Brii Biosciences and Ideaya Biosciences had a busy end to the year, sharing news of agreements for ...
VBI Vaccines ( (VBIVQ) ) has shared an announcement.
A biotechnology firm in Durham is expanding its portfolio with an $18 million deal. STORY HIGHLIGHTS Brii Biosciences ...
Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced its participation in BIO Partnering @ JPM Week 2025 in San Francisco January 13-16 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (VBI) is initiating a voluntary nationwide recall of all remaining PreHevbrio ® [Hepatitis B Vaccine (Recombinant); NDC 75052-001-10 ...
CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies ...
VBI Vaccines Inc. has completed a restructuring process under the Companies’ Creditors Arrangement Act, resulting in the acquisition by K2 VBI Equity Trust, LLC. All common shares have been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback